Genmab — December 2015
-
Så går det løs. Dejligt at folk tweeter billeder af slides så vi kan følge med
-
"Ikke meget nyt om Elo".
-
multiple mechanisms of action https://pbs.twimg.com/media/CVdy1ThUkAAoark.jpg:large
-
@Carolinas Dr. Saad Usmani on stage presenting #daratumumab study ground-breaking results #ASH15 @szusmani #cancer
-
-
Jeg har sgu fået kuldegysninger.
-
-
-
Janssen update - Daratumumab mono - 70% response. 50% of responders progression-free at 12 months. Dara is Rituxan for MM.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind